The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
A new look at international research ethics
Open accessAbstract
Editorial by Lansang The normal “standard of care” against which new interventions are tested in medical research has not been formally defined. It is usually taken to mean the “best proved treatment” for any condition under investigation in a trial. We reject the arbitrariness of this notion of the standard of care and offer a more comprehensive alternative. Use of this new standard invokes a new approach to international research ethics that focuses on reducing inequalities in global health. The debate on what constitutes a fair and reasonable standard of care for subjects in developing countries who participate in clinical trials has been rekindled by critics of studies on the transmission of HIV.1-3 They argued that placebo controlled trials of new regimens to prevent the vertical transmission of HIV were unethical because they included a placebo arm rather than “the best proven treatment” available in developed countries. Some commentators considered the criticisms to be unfounded4-6 and associated with imperialistic attitudes.7 The debate made it clear that the high standards of research aspired to have not been adequately defined. It was also marred by simplistic notions of ethics. Although there was justified concern that pressure from the US Food and Drug Administration could “dilute” the Declaration of Helsinki, critics also presumed that whether a trial was ethical could simply be deduced from the text of a declaration. But declarations—such as the Declaration of Helsinki, governing international research ethics—are like constitutions, needing interpretation. Determining what is ethical goes beyond merely following prescriptions and requires moral reasoning: consideration of all relevant aspects of the case in its context, weighing and balancing competing moral requirements, and developing justifiable conclusions. Although more mature insight is gradually emerging into the complexity associated with the ethics of research in developing countries, the debate remains …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lurie, P., & Wolfe, S. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709183371212 · Cited by 882
The Ethics of Clinical Research in the Third World
Angell, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709183371209 · Cited by 863
Percival, T. (1803) · Cited by 575
Ethical Complexities of Conducting Research in Developing Countries
Varmus, H., & Satcher, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371411 · Cited by 424
Berlin, L. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.170.2.9456928 · Cited by 272
Health research, essential link to equity in development
Campbell, P. N. (1992) · Biochemical Education · doi:10.1016/0307-4412(92)90037-m · Cited by 267
Global disparities in health and human rights: a critical commentary.
Benatar, S. R. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.2.295 · Cited by 213
Self-citationNorth-South research partnerships: the ethics of carrying out research in developing countries
Edejer, T. T.-T. (1999) · BMJ · doi:10.1136/bmj.319.7207.438 · Cited by 200
Protecting communities in research: current guidelines and limits of extrapolation
Weijer, C., Goldsand, G., & Emanuel, E. J. (1999) · Nature Genetics · doi:10.1038/15455 · Cited by 183
Investigators' Responsibilities for Human Subjects in Developing Countries
Angell, M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421309 · Cited by 177
Fairchild, A. L., & Bayer, R. (1999) · Science · doi:10.1126/science.284.5416.919 · Cited by 149
Updating Protections for Human Subjects Involved in Research
Moreno, J. D. (1998) · JAMA · doi:10.1001/jama.280.22.1951 · Cited by 134
Imperialism, research ethics and global health.
Benatar, S. R. (1998) · Journal of Medical Ethics · doi:10.1136/jme.24.4.221 · Cited by 127
Self-citationAvoiding Exploitation in Clinical Research
Benatar, S. R. (2000) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s096318010000414x · Cited by 118
Self-citationChallenges to Human Subject Protections in US Medical Research
Woodward, B. (1999) · JAMA · doi:10.1001/jama.282.20.1947 · Cited by 117
Conflicts of interest in clinical practice and research
Spece, R. G., Shimm, D. S., & Buchanan, A. E. (1996) · Cited by 75
Recent advances: Medical ethics
SINGER, P. A. (2000) · BMJ · doi:10.1136/bmj.321.7256.282 · Cited by 64
Problems in Clinical Trials Go Far Beyond Misconduct
Nowak, R. (1994) · Science · doi:10.1126/science.8202708 · Cited by 51
Ryan, C. J. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63977-3 · Cited by 29
Keeping Research Subjects Out of Harm's Way
Ellis, G. B. (1999) · JAMA · doi:10.1001/jama.282.20.1963 · Cited by 23
Bloom, B. R. (1999) · Nature · doi:10.1038/35011557 · Cited by 21
Capital Report: A Gene Therapy Death
Silberner, J. (2000) · The Hastings Center Report · doi:10.2307/3528305 · Cited by 8
Cited by
Gender equality in science, medicine, and global health: where are we at and why does it matter?
Shannon, G., Jansen, M., Williams, K., Cáceres, C., Motta, A., Odhiambo, A., Eleveld, A., & Mannell, J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33135-0 · Cited by 534
Genetic analysis of African populations: human evolution and complex disease
Tishkoff, S. A., & Williams, S. M. (2002) · Nature Reviews Genetics · doi:10.1038/nrg865 · Cited by 427
Reflections and recommendations on research ethics in developing countries
Benatar, S. R. (2002) · Social Science & Medicine · doi:10.1016/s0277-9536(01)00327-6 · Cited by 373
Self-citationEthical variability: Drug development and globalizing clinical trials
Petryna, A. (2005) · American Ethnologist · doi:10.1525/ae.2005.32.2.183 · Cited by 316
Sumathipala, A., Siribaddana, S., & Patel, V. (2004) · BMC Medical Ethics · doi:10.1186/1472-6939-5-5 · Cited by 255
Metadata
- Authors
- Benatar, S. R.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-09-30
- Volume
- 321
- Issue
- 7264
- Pages
- 824-826
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W2139562275
- Cited by
- 325
- References
- 22
- FWCI
- 12.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.